Imunon (IMNN) Long-Term Investments (2021 - 2023)
Imunon's (IMNN) quarterly Long-Term Investments came in at $3.8 million in Q1 2023, down 37.5% YoY from $6.0 million in Q1 2022, and down 16.67% on a QoQ basis from $4.5 million in Q4 2022.
Imunon (IMNN) Long-Term Investments (2021 - 2023) Analysis & Trends
Imunon (IMNN) has 3 years of Long-Term Investments data on file, last reported at $3.8 million in Q1 2023.
- Quarterly Long-Term Investments fell 37.5% year-over-year to $3.8 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $3.8 million (down 37.5% YoY) and the FY2022 annual result came in at $4.5 million, down 25.0% from the prior year.
- Long-Term Investments retreated to $3.8 million in Q1 2023, from $4.5 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $6.0 million in Q2 2021 to a low of $3.8 million in Q1 2023.
- A 3-year average of $5.5 million and a median of $6.0 million in 2021 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments changed 0.0% — and 2023, when it tumbled 37.5%.
- Tracing IMNN's Long-Term Investments over 3 years: stood at $6.0 million in 2021, then retreated by 25.0% to $4.5 million in 2022, then fell by 16.67% to $3.8 million in 2023.
- The last three Long-Term Investments figures came in at $3.8 million (Q1 2023), $4.5 million (Q4 2022), and $6.0 million (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3.75 Mn |
| Dec 31, 2022 | 4.50 Mn |
| Sep 30, 2022 | 6.00 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Mar 31, 2022 | 6.00 Mn |
| Dec 31, 2021 | 6.00 Mn |
| Sep 30, 2021 | 6.00 Mn |
| Jun 30, 2021 | 6.00 Mn |